Medical Device Industry News

Cohera's Sylys sealant wins quick review at FDA

December 18, 2014 by Val Kennedy

The FDA awards priority review status to Cohera Medical's surgical sealant Sylys because the product addresses a significant unmet medical need.

Cohera's Sylys sealant wins quick review at FDA

The FDA awarded priority review status to Cohera Medical's surgical sealant Sylys because the product addresses a significant unmet medical need.

MassDevice.com +3 | The top 3 medtech stories for December 18, 2014

December 18, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Sorin wins FDA nod for Memo3d ReChord mitral annuloplasty ring

December 18, 2014 by Mark Hollmer

Sorin Group is beginning a U.S. rollout of a new surgical implant ring for addressing mitral valve repair issues.

Sorin wins FDA nod for Memo3d ReChord annuloplasty ring

Italy's Sorin Group (BIT:SRN) nailed down FDA clearance for a new surgical implant designed for use in mitral valve repair.

Sonoma Orthopedic raises $12 million for ankle implant

December 18, 2014 by Brad Perriello

Sonoma Orthopedic Products raises $12 million from First Analysis for its 'flexible-to-rigid' ankle implants.

Sonoma Orthopedic raises $12 million for ankle implant

Sonoma Orthopedic Products added $12 million to its coffers, thanks to private equity shop First Analysis, saying it plans to use the proceeds to get its "flexible-to rigid" ankle implant on the U.S. market.

FDA OKs expedited enrollment for InVivo study

December 18, 2014 by Val Kennedy

The FDA approves an expedited enrollment plan for a 5-patient pivotal study testing InVivo Therapeutics' neuro-spinal scaffold devices in the treatment of severe spinal cord injuries.

FDA OKs expedited enrollment for InVivo study

AliveCor plans January debut on Amazon for 3rd-gen home heart monitor

December 18, 2014 by Mark Hollmer

AliveCor said it will start selling its 3rd-generation at-home heart monitor on Amazon.com in January, with help from Japanese medtech titan Omron Healthcare.

AliveCor plans January debut on Amazon for 3rd-gen home heart monitor

AliveCor is rolling out a 3rd-generation version of its at-home heart monitor, with plans to put the device on the market at Amazon.com next month.

Aethlon sells $3.3m in securities to investment fund

December 18, 2014 by Val Kennedy

Aethlon Medical deals $3.3 million in securities to an unnamed healthcare-focused investment fund, according to a recent regulatory filing and the company.

Aethlon sells $3.3m in securities to investment fund

Aethlon Medical (OTC:AEMD) said it dealt $3.3 million worth of securities an investment fund, as it pursues various approvals for its Hemopurifier blood filtration device.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp